Fortress Biotech (FBIO) Earnings Date, Estimates & Call Transcripts

$1.72
0.00 (0.00%)
(As of 04/26/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 20Estimated
Actual EPS
(Mar. 28)
-$0.53 Missed By -$0.53
Skip Charts & View Estimated and Actual Earnings Data

FBIO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

FBIO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Fortress Biotech Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($2.60)($1.46)($2.03)
Q2 20242($2.24)($1.42)($1.83)
Q3 20242($2.08)($0.94)($1.51)
Q4 20242($1.30)($1.15)($1.23)
FY 20248($8.22)($4.97)($6.60)

FBIO Earnings Date and Information

Fortress Biotech last released its quarterly earnings data on March 28th, 2024. The biopharmaceutical company reported ($0.53) earnings per share for the quarter. The company had revenue of $19.95 million for the quarter, compared to analyst estimates of $14.46 million. Fortress Biotech has generated ($8.22) earnings per share over the last year (($8.22) diluted earnings per share). Earnings for Fortress Biotech are expected to grow in the coming year, from ($6.57) to ($5.57) per share. Fortress Biotech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off prior year's report dates.

Fortress Biotech Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/20/2024
Estimated)
------- 
3/28/2024Q4 2023-($0.53)($0.53)($0.53)$14.46 million$19.95 million
11/14/2023Q3 2023($3.53)($0.94)+$2.59($0.94)$13.30 million$34.75 million
8/14/2023Q2 2023($3.90)($3.60)+$0.30($0.24)$13.28 million$17.39 million
5/15/2023Q1 2023($2.85)($3.15)($0.30)($0.21)$16.35 million$12.43 million
3/30/2023Q4 2022($3.30)($4.50)($1.20)($0.30)$25.20 million$16.40 million
11/14/2022Q3 2022($4.05)($3.75)+$0.30($0.25)$19.02 million$16.53 million
8/11/2022Q2 2022($3.00)($3.60)($0.60)($0.24)$22.85 million$18.89 million
5/12/2022Q1 2022($4.20)($2.70)+$1.50($0.18)$20.06 million$23.93 million    
3/28/2022Q4 2021$1.50($5.70)($7.20)($0.38)$29.93 million$18.28 million
11/15/2021Q3 2021($1.20)($2.10)($0.90)($0.26)$18.41 million$21.09 million
8/15/2021Q2 2021($2.10)($4.35)($2.25)($0.04)$13.82 million$17.84 million
5/17/2021Q1($2.4450)($1.65)+$0.7950($0.11)$13.51 million$11.59 million

Fortress Biotech Earnings - Frequently Asked Questions

When is Fortress Biotech's earnings date?

Fortress Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off last year's report dates. Learn more on FBIO's earnings history.

How much revenue does Fortress Biotech generate each year?

Fortress Biotech (NASDAQ:FBIO) has a recorded annual revenue of $84.51 million.

How much profit does Fortress Biotech generate each year?

Fortress Biotech (NASDAQ:FBIO) has a recorded net income of -$60.64 million. FBIO has generated -$8.22 earnings per share over the last four quarters.

What is Fortress Biotech's EPS forecast for next year?

Fortress Biotech's earnings are expected to grow from ($6.57) per share to ($5.57) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:FBIO) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners